P. Morin

Comparison of sub‐2‐μm particle columns for fast metabolite ID

M. Walles, J. Ducharme, Caroline Gauvin, 2007 .

Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N -demethylation in human liver microsomes

D Projean, P-E Morin, T M Tu, 2003, Xenobiotica; the fate of foreign compounds in biological systems.

Delta agonist hydroxy bioisosteres: the discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability.

L. Adam, P. Morin, C. Walpole, 2009, Bioorganic & Medicinal Chemistry Letters.

N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues.

S. Yue, D. Delorme, K Payza, 2000, Journal of medicinal chemistry.

New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability.

S. Yue, D. Delorme, H. Gagnon, 2000, Journal of medicinal chemistry.

Refinement of an in vitro cell model for cytochrome P450 induction.

B. Kennedy, T. Rushmore, P. Payette, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Reactive metabolite trapping screens and potential pitfalls: bioactivation of a homomorpholine and formation of an unstable thiazolidine adduct.

D. Weston, E. Lenz, M. Bayrakdarian, 2014, Chemical research in toxicology.

Oxidative bioactivation of the lactol prodrug of a lactone cyclooxygenase-2 inhibitor.

J. Falgueyret, D. Riendeau, Z. Wang, 1999, Drug metabolism and disposition: the biological fate of chemicals.